annual CFF:
$128.53M+$55.82M(+76.78%)Summary
- As of today (July 16, 2025), TGTX annual cash flow from financing activities is $128.53 million, with the most recent change of +$55.82 million (+76.78%) on December 31, 2024.
- During the last 3 years, TGTX annual CFF has risen by +$87.11 million (+210.31%).
- TGTX annual CFF is now -81.09% below its all-time high of $679.83 million, reached on December 31, 2020.
Performance
TGTX Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$6.10M-$30.00K(-0.49%)Summary
- As of today (July 16, 2025), TGTX quarterly cash flow from financing activities is -$6.10 million, with the most recent change of -$30.00 thousand (-0.49%) on March 1, 2025.
- Over the past year, TGTX quarterly CFF has dropped by -$6.11 million (-61120.00%).
- TGTX quarterly CFF is now -101.51% below its all-time high of $403.39 million, reached on December 31, 2020.
Performance
TGTX quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$122.42M-$6.11M(-4.76%)Summary
- As of today (July 16, 2025), TGTX TTM cash flow from financing activities is $122.42 million, with the most recent change of -$6.11 million (-4.76%) on March 1, 2025.
- Over the past year, TGTX TTM CFF has increased by +$74.94 million (+157.84%).
- TGTX TTM CFF is now -81.99% below its all-time high of $679.83 million, reached on December 31, 2020.
Performance
TGTX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
TGTX Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +76.8% | -10000.0% | +157.8% |
| 3 y3 years | +210.3% | -617.9% | +201.3% |
| 5 y5 years | -37.1% | -7633.3% | -66.0% |
TGTX Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -104.5% | at low | -9.1% | >+9999.0% |
| 5 y | 5-year | -81.1% | >+9999.0% | -101.5% | +17.1% | -82.0% | >+9999.0% |
| alltime | all time | -81.1% | >+9999.0% | -101.5% | +72.1% | -82.0% | +6407.1% |
TGTX Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$6.10M(+0.5%) | $122.42M(-4.8%) |
| Dec 2024 | $128.53M(+76.8%) | -$6.07M(-104.5%) | $128.53M(-4.5%) |
| Sep 2024 | - | $134.45M(>+9900.0%) | $134.60M(>+9900.0%) |
| Jun 2024 | - | $135.00K(+1250.0%) | $565.00K(-98.8%) |
| Mar 2024 | - | $10.00K(-1100.0%) | $47.48M(-34.7%) |
| Dec 2023 | $72.70M(<-9900.0%) | -$1000.00(-100.2%) | $72.70M(-0.1%) |
| Sep 2023 | - | $421.00K(-99.1%) | $72.75M(+0.2%) |
| Jun 2023 | - | $47.05M(+86.4%) | $72.61M(+182.6%) |
| Mar 2023 | - | $25.24M(>+9900.0%) | $25.70M(-6672.1%) |
| Dec 2022 | -$391.00K(-100.9%) | $49.00K(-82.2%) | -$391.00K(-100.7%) |
| Sep 2022 | - | $275.00K(+103.7%) | $55.56M(+15.9%) |
| Jun 2022 | - | $135.00K(-115.9%) | $47.92M(+18.0%) |
| Mar 2022 | - | -$850.00K(-101.5%) | $40.62M(-1.9%) |
| Dec 2021 | $41.42M(-93.9%) | $56.00M(-860.7%) | $41.42M(-89.3%) |
| Sep 2021 | - | -$7.36M(+2.8%) | $388.81M(-9.9%) |
| Jun 2021 | - | -$7.16M(>+9900.0%) | $431.44M(-36.5%) |
| Mar 2021 | - | -$55.00K(-100.0%) | $679.69M(-0.0%) |
| Dec 2020 | $679.83M(+232.9%) | $403.39M(+1043.9%) | $679.83M(+81.4%) |
| Sep 2020 | - | $35.27M(-85.4%) | $374.79M(+4.0%) |
| Jun 2020 | - | $241.09M(>+9900.0%) | $360.22M(+144.4%) |
| Mar 2020 | - | $81.00K(-99.9%) | $147.41M(-27.8%) |
| Dec 2019 | $204.21M(+79.7%) | $98.35M(+375.3%) | $204.21M(+84.7%) |
| Sep 2019 | - | $20.70M(-26.8%) | $110.55M(+17.2%) |
| Jun 2019 | - | $28.28M(-50.3%) | $94.35M(-20.1%) |
| Mar 2019 | - | $56.88M(+1111.8%) | $118.09M(+3.9%) |
| Dec 2018 | $113.64M(-15.0%) | $4.69M(+4.5%) | $113.64M(-8.1%) |
| Sep 2018 | - | $4.49M(-91.4%) | $123.68M(-16.1%) |
| Jun 2018 | - | $52.02M(-0.8%) | $147.41M(+48.6%) |
| Mar 2018 | - | $52.43M(+255.7%) | $99.18M(-25.8%) |
| Dec 2017 | $133.66M(+2564.7%) | $14.74M(-47.8%) | $133.66M(+11.1%) |
| Sep 2017 | - | $28.22M(+643.3%) | $120.34M(+30.6%) |
| Jun 2017 | - | $3.80M(-95.6%) | $92.17M(+0.3%) |
| Mar 2017 | - | $86.91M(+6016.9%) | $91.91M(+1732.4%) |
| Dec 2016 | $5.02M(-92.7%) | $1.42M(+3085.7%) | $5.02M(+38.7%) |
| Sep 2016 | - | $44.60K(-98.7%) | $3.62M(-81.3%) |
| Jun 2016 | - | $3.54M(>+9900.0%) | $19.32M(-42.2%) |
| Mar 2016 | - | $14.20K(-34.3%) | $33.41M(-51.4%) |
| Dec 2015 | $68.72M(+0.1%) | $21.60K(-99.9%) | $68.72M(-28.0%) |
| Sep 2015 | - | $15.74M(-10.7%) | $95.43M(-8.1%) |
| Jun 2015 | - | $17.63M(-50.1%) | $103.89M(+20.1%) |
| Mar 2015 | - | $35.33M(+32.2%) | $86.53M(+26.1%) |
| Dec 2014 | $68.64M(+72.9%) | $26.73M(+10.4%) | $68.64M(+63.6%) |
| Sep 2014 | - | $24.20M(+8771.0%) | $41.96M(-24.6%) |
| Jun 2014 | - | $272.80K(-98.4%) | $55.69M(-0.9%) |
| Mar 2014 | - | $17.44M(>+9900.0%) | $56.20M(+41.6%) |
| Dec 2013 | $39.69M(+233.7%) | $48.40K(-99.9%) | $39.69M(+0.3%) |
| Sep 2013 | - | $37.92M(+4719.8%) | $39.56M(+2313.4%) |
| Jun 2013 | - | $786.80K(-16.0%) | $1.64M(+105.7%) |
| Mar 2013 | - | $936.90K(-1208.8%) | $796.90K(-93.3%) |
| Dec 2012 | $11.90M(+21.1%) | -$84.50K(<-9900.0%) | $11.90M(-45.4%) |
| Sep 2012 | - | $0.00(-100.0%) | $21.78M(-0.1%) |
| Jun 2012 | - | -$55.50K(-100.5%) | $21.81M(>+9900.0%) |
| Mar 2012 | - | $12.04M(+22.9%) | $0.00(-100.0%) |
| Dec 2011 | $9.82M(+413.2%) | $9.79M(>+9900.0%) | $9.82M(<-9900.0%) |
| Sep 2011 | - | $30.10K(-100.1%) | -$25.50K(-81.6%) |
| Jun 2011 | - | -$21.86M(-200.0%) | -$138.90K(-100.6%) |
| Mar 2011 | - | $21.86M(<-9900.0%) | $21.69M(+1033.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2010 | $1.91M(+93.6%) | -$55.60K(-33.3%) | $1.91M(-12.5%) |
| Sep 2010 | - | -$83.30K(+163.6%) | $2.19M(-3.7%) |
| Jun 2010 | - | -$31.60K(-101.5%) | $2.27M(-1.4%) |
| Mar 2010 | - | $2.08M(+854.1%) | $2.30M(+132.9%) |
| Dec 2009 | $988.80K(-74.7%) | $218.50K(>+9900.0%) | $988.80K(-43.8%) |
| Sep 2009 | - | $0.00(0.0%) | $1.76M(-3.6%) |
| Jun 2009 | - | $0.00(-100.0%) | $1.83M(-32.9%) |
| Mar 2009 | - | $770.30K(-22.2%) | $2.72M(-30.4%) |
| Dec 2008 | $3.91M(-50.3%) | $990.10K(+1402.4%) | $3.91M(+33.9%) |
| Sep 2008 | - | $65.90K(-92.6%) | $2.92M(+2.4%) |
| Jun 2008 | - | $894.50K(-54.3%) | $2.85M(+44.7%) |
| Mar 2008 | - | $1.96M(>+9900.0%) | $1.97M(-74.9%) |
| Dec 2007 | $7.86M(<-9900.0%) | $0.00(-100.0%) | $7.86M(0.0%) |
| Sep 2007 | - | -$2000.00(-114.9%) | $7.86M(-0.0%) |
| Jun 2007 | - | $13.40K(-99.8%) | $7.86M(+0.2%) |
| Mar 2007 | - | $7.85M(>+9900.0%) | $7.84M(<-9900.0%) |
| Dec 2006 | -$15.30K(-100.1%) | $0.00(0.0%) | -$15.30K(-202.0%) |
| Sep 2006 | - | $0.00(-100.0%) | $15.00K(-99.9%) |
| Jun 2006 | - | -$5100.00(-50.0%) | $11.92M(+2.6%) |
| Mar 2006 | - | -$10.20K(-133.7%) | $11.62M(-0.7%) |
| Dec 2005 | $11.70M(+245.0%) | $30.30K(-99.7%) | $11.70M(+0.3%) |
| Sep 2005 | - | $11.91M(-3978.2%) | $11.67M(-4829.7%) |
| Jun 2005 | - | -$307.00K(-544.9%) | -$246.70K(-1651.6%) |
| Mar 2005 | - | $69.00K(>+9900.0%) | $15.90K(-99.5%) |
| Dec 2004 | $3.39M(-62.3%) | $0.00(-100.0%) | $3.39M(-72.7%) |
| Sep 2004 | - | -$8700.00(-80.4%) | $12.42M(+0.3%) |
| Jun 2004 | - | -$44.40K(-101.3%) | $12.38M(-0.4%) |
| Mar 2004 | - | $3.44M(-61.9%) | $12.42M(+38.2%) |
| Dec 2003 | $8.98M(+261.3%) | $9.03M(<-9900.0%) | $8.98M(+262.1%) |
| Sep 2003 | - | -$51.10K(<-9900.0%) | $2.48M(+30.9%) |
| Jun 2003 | - | $0.00(-100.0%) | $1.89M(-25.2%) |
| Mar 2003 | - | $7700.00(-99.7%) | $2.53M(+1.9%) |
| Dec 2002 | $2.49M(+386.8%) | $2.52M(-496.0%) | $2.49M(+30.7%) |
| Sep 2002 | - | -$637.40K(-199.8%) | $1.90M(-25.1%) |
| Jun 2002 | - | $638.80K(-1746.4%) | $2.54M(+133.1%) |
| Mar 2002 | - | -$38.80K(-102.0%) | $1.09M(+113.3%) |
| Dec 2001 | $510.80K(-22.8%) | $1.94M(<-9900.0%) | $510.90K(-126.3%) |
| Sep 2001 | - | -$400.00(-100.0%) | -$1.94M(+78.3%) |
| Jun 2001 | - | -$811.10K(+31.3%) | -$1.09M(+292.4%) |
| Mar 2001 | - | -$617.60K(+20.7%) | -$277.40K(-142.0%) |
| Dec 2000 | $661.30K(>+9900.0%) | -$511.80K(-160.1%) | $661.20K(-43.6%) |
| Sep 2000 | - | $852.00K(>+9900.0%) | $1.17M(+265.4%) |
| Jun 2000 | - | $0.00(-100.0%) | $321.00K(0.0%) |
| Mar 2000 | - | $321.00K(>+9900.0%) | $321.00K(>+9900.0%) |
| Dec 1999 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 1999 | - | $0.00(0.0%) | $100.00K(0.0%) |
| Jun 1999 | - | $0.00(0.0%) | $100.00K(0.0%) |
| Mar 1999 | - | $0.00(-100.0%) | $100.00K(0.0%) |
| Dec 1998 | $100.00K(-99.1%) | $100.00K(>+9900.0%) | $100.00K(-200.0%) |
| Sep 1998 | - | $0.00(0.0%) | -$100.00K(-101.2%) |
| Jun 1998 | - | $0.00(0.0%) | $8.60M(-18.9%) |
| Mar 1998 | - | $0.00(-100.0%) | $10.60M(0.0%) |
| Dec 1997 | $10.60M(+715.4%) | -$100.00K(-101.1%) | $10.60M(-0.9%) |
| Sep 1997 | - | $8.70M(+335.0%) | $10.70M(+435.0%) |
| Jun 1997 | - | $2.00M(>+9900.0%) | $2.00M(>+9900.0%) |
| Mar 1997 | - | $0.00 | $0.00 |
| Dec 1996 | $1.30M | - | - |
FAQ
- What is TG Therapeutics, Inc. annual cash flow from financing activities?
- What is the all time high annual CFF for TG Therapeutics, Inc.?
- What is TG Therapeutics, Inc. annual CFF year-on-year change?
- What is TG Therapeutics, Inc. quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for TG Therapeutics, Inc.?
- What is TG Therapeutics, Inc. quarterly CFF year-on-year change?
- What is TG Therapeutics, Inc. TTM cash flow from financing activities?
- What is the all time high TTM CFF for TG Therapeutics, Inc.?
- What is TG Therapeutics, Inc. TTM CFF year-on-year change?
What is TG Therapeutics, Inc. annual cash flow from financing activities?
The current annual CFF of TGTX is $128.53M
What is the all time high annual CFF for TG Therapeutics, Inc.?
TG Therapeutics, Inc. all-time high annual cash flow from financing activities is $679.83M
What is TG Therapeutics, Inc. annual CFF year-on-year change?
Over the past year, TGTX annual cash flow from financing activities has changed by +$55.82M (+76.78%)
What is TG Therapeutics, Inc. quarterly cash flow from financing activities?
The current quarterly CFF of TGTX is -$6.10M
What is the all time high quarterly CFF for TG Therapeutics, Inc.?
TG Therapeutics, Inc. all-time high quarterly cash flow from financing activities is $403.39M
What is TG Therapeutics, Inc. quarterly CFF year-on-year change?
Over the past year, TGTX quarterly cash flow from financing activities has changed by -$6.11M (-61120.00%)
What is TG Therapeutics, Inc. TTM cash flow from financing activities?
The current TTM CFF of TGTX is $122.42M
What is the all time high TTM CFF for TG Therapeutics, Inc.?
TG Therapeutics, Inc. all-time high TTM cash flow from financing activities is $679.83M
What is TG Therapeutics, Inc. TTM CFF year-on-year change?
Over the past year, TGTX TTM cash flow from financing activities has changed by +$74.94M (+157.84%)